Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab | 4件: Bortezomib Bortezomib,Cyclophosphamide, Daratumumab, Dexamethasone | 5件: Cyclophosphamide
Cyclophosphamide
,Dexamethasone , Bortezomib , Cyclophosphamide , Daratumumab 💬 1. Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
| 3件: CD38 CD38,NR3C1, PSMB5 💬 | 16件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell ... | 1件: 28 28 💬1. Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
| ||||||||||||||||||||
| 2 | Daratumumab | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬2. Daratumumab
| 1件: CD38 CD38 💬2. Daratumumab
| 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | 5件: 13 13, 28, 48, 49, 63 💬
| ||||||||||||||||||||
| 3 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | 3件: Daratumumab Daratumumab,Hyaluronidase, Hyaluronidase (human recombinant) | 4件: Hyaluronidase
Hyaluronidase
,Hyaluronidase , Hyaluronidase , Daratumumab 💬 3. Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)
| 1件: CD38 CD38 💬3. Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)
| 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | 1件: 28 28 💬3. Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)
| ||||||||||||||||||||
| 4 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬4. Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)
| 1件: CD38 CD38 💬4. Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)
| 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | 1件: 28 28 💬4. Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)
| ||||||||||||||||||||
| 5 | Daratumumab Injection | 1件: Daratumumab Daratumumab | 1件: Daratumumab
Daratumumab
💬5. Daratumumab Injection
| 1件: CD38 CD38 💬5. Daratumumab Injection
| 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicoti ... | 3件: 28 28, 49, 63 💬
|